Trial · NCT01200758
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Stage I | STARTED | Stage I: Rituximab IV + Chemotherapy (CHOP/CVP) | 64 | |
| Stage I | STARTED | Stage I: Rituximab SC + Chemotherapy (CHOP/CVP) | 63 | |
| Stage I | STARTED | Stage II: Rituximab IV + Chemotherapy (CHOP/CVP) | 0 | |
| Stage I | STARTED | Stage II: Rituximab SC + Chemotherapy (CHOP/CVP) | 0 | |
| Stage I | COMPLETED | Stage I: Rituximab IV + Chemotherapy (CHOP/CVP) | 46 | |
| Stage I | COMPLETED | Stage I: Rituximab SC + Chemotherapy (CHOP/CVP) | 46 | |
| Stage I | COMPLETED | Stage II: Rituximab IV + Chemotherapy (CHOP/CVP) | 0 | |
| Stage I | COMPLETED | Stage II: Rituximab SC + Chemotherapy (CHOP/CVP) | 0 | |
| Stage I | NOT COMPLETED | Stage I: Rituximab IV + Chemotherapy (CHOP/CVP) | 18 | |
| Stage I | NOT COMPLETED | Stage I: Rituximab SC + Chemotherapy (CHOP/CVP) | 17 | |
| Stage I | NOT COMPLETED | Stage II: Rituximab IV + Chemotherapy (CHOP/CVP) | 0 | |
| Stage I | NOT COMPLETED | Stage II: Rituximab SC + Chemotherapy (CHOP/CVP) | 0 | |
| Stage 2 | STARTED | Stage I: Rituximab IV + Chemotherapy (CHOP/CVP) | 0 | |
| Stage 2 | STARTED | Stage I: Rituximab SC + Chemotherapy (CHOP/CVP) | 0 | |
| Stage 2 | STARTED | Stage II: Rituximab IV + Chemotherapy (CHOP/CVP) | 141 | |
| Stage 2 | STARTED | Stage II: Rituximab SC + Chemotherapy (CHOP/CVP) | 142 | |
| Stage 2 | COMPLETED | Stage I: Rituximab IV + Chemotherapy (CHOP/CVP) | 0 | |
| Stage 2 | COMPLETED | Stage I: Rituximab SC + Chemotherapy (CHOP/CVP) | 0 | |
| Stage 2 | COMPLETED | Stage II: Rituximab IV + Chemotherapy (CHOP/CVP) | 100 | |
| Stage 2 | COMPLETED | Stage II: Rituximab SC + Chemotherapy (CHOP/CVP) | 92 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01200758/flow